Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
blueprint medicines
4
×
boston blog main
life sciences
4
×
national blog main
avapritinib
boston
boston top stories
cancer
clinical trials
national top stories
roche
san francisco blog main
san francisco top stories
biotech
eli lilly
fda
genentech
indiana blog main
indiana top stories
medullary thyroid cancer
non-small cell lung cancer
pralsetinib
selpercatinib
thyroid cancer
andrew berens
boulder/denver blog main
boulder/denver top stories
cancer drugs
capmatinib
companion diagnostic
cstone pharmaceuticals
deals
deciphera pharmaceuticals
detroit blog main
detroit top stories
dna sequencing
drugs
entrectinib
europe blog main
europe top stories
What
cancer
4
×
drug
fda
4
×
approval
blueprint
genetic
medicine
medicines
ret
address
announced
approved
approves
candidate
carries
certain
chasing
currently
deadly
deciphera
deeper
designed
dna
filing
fingerprint
forms
gi
going
latest
marketing
matter
morning
muscle
nd
new
oks
pact
pass
pharamceuticals
plans
Language
unset
Current search:
fda
×
cancer
×
" blueprint medicines "
×
" life sciences "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues